Advanced Lung Cancer Patients’ Use of EGFR Tyrosine Kinase Inhibitors and Overall Survival: Real-World Evidence from Quebec, Canada

por Qureshi, Samia, Boily, Gino, Boulanger, Jim, Golo, Kossi Thomas, Guédon, Aude-Christine, Lehuédé, Camille, Roussafi, Ferdaous, Truchon, Catherine, Strumpf, Erin
Publicado 2022